Bhupesh S. Bhatt
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Bhupesh S. Bhatt has a total of 77 co-authors. Here are the top co-authors by number of shared publications:
- Mohan N. Patel
Department of Chemistry, Sardar Patel University, Vallabh Vidyanagar, Gujarat 388 120, India
35 shared publications Promise A. Dosi
15 shared publicationsForam U. Vaidya
Department of Chemistry, Sardar Patel University, Vallabh Vidyanagar, Gujarat, India
8 shared publicationsBhavesh N. Socha
Department of Materials Science, Sardar Patel University, Vallabh Vidyanagar-388 120, Gujarat, India
7 shared publicationsMilan P. Dhaduk
Department of Chemistry, Sardar Patel University, Vallabh Vidyanagar, Gujarat 388 120, India
7 shared publicationsVaibhav D. Bhatt
School of Applied Sciences and Technology, Gujarat Technological University, Ahmedabad, Gujarat, India
7 shared publications
Latest Publications
- Open Access
- 2 November 2026
- Published by Royal Society of Chemistry (RSC) in Materials Advances
- Vol. 7 (21) , 10909-10928
Integrated experimental and computational investigation of catalyst-free synthesized spiro-thiazolidinones through single-crystal XRD, biomolecular binding and anticancer evaluation
Catalyst-free synthesis of spiro-thiazolidinones was confirmed by single-crystal XRD and computational studies. Their biomolecular interactions and anticancer activities were evaluated to assess binding profiles and therapeutic potential.
- 2 November 2026
- Published by Royal Society of Chemistry (RSC) in Materials Advances
- Vol. 7 (21) , 10909-10928
Open AccessIntegrated experimental and computational investigation of catalyst-free synthesized spiro-thiazolidinones through single-crystal XRD, biomolecular binding and anticancer evaluation
Catalyst-free synthesis of spiro-thiazolidinones was confirmed by single-crystal XRD and computational studies. Their biomolecular interactions and anticancer activities were evaluated to assess binding profiles and therapeutic potential.
- 5 October 2026
- Published by Royal Society of Chemistry (RSC) in New Journal of Chemistry
- Vol. 50 (38) , 16306-16322
Structural characterization and biomolecular interaction studies of mono- and mixed-ligand copper( ii ) complexes: X-ray crystallography, computational analysis, and DNA/BSA binding investigations
Two new copper( ii ) complexes have been synthesized and characterized well for DNA and BSA protein binding studies, showcasing the structure–activity relationship of the systems.
- 5 October 2026
- Published by Royal Society of Chemistry (RSC) in New Journal of Chemistry
- Vol. 50 (38) , 16306-16322
Structural characterization and biomolecular interaction studies of mono- and mixed-ligand copper( ii ) complexes: X-ray crystallography, computational analysis, and DNA/BSA binding investigations
Two new copper( ii ) complexes have been synthesized and characterized well for DNA and BSA protein binding studies, showcasing the structure–activity relationship of the systems.
- 16 September 2025
- Published by Elsevier in Journal of Trace Elements in Medicine and Biology
- Vol. 92, 127747
Heteroleptic N, N donor carbonitrile based Au(III) complexes: DNA/BSA interaction studies, Molecular Docking, and cytotoxicity studies
- 16 September 2025
- Published by Elsevier in Journal of Trace Elements in Medicine and Biology
- Vol. 92, 127747
Heteroleptic N, N donor carbonitrile based Au(III) complexes: DNA/BSA interaction studies, Molecular Docking, and cytotoxicity studies
- 12 September 2025
- Published by Elsevier in Next Research
- Vol. 2 (4)
Exploring spiranes with heterocyclic frameworks: Unveiling their potential as versatile biologically active scaffolds
- 12 September 2025
- Published by Elsevier in Next Research
- Vol. 2 (4)
Exploring spiranes with heterocyclic frameworks: Unveiling their potential as versatile biologically active scaffolds
- 30 May 2025
- Published by Wiley in ChemistrySelect
- Vol. 10 (21)
Synthesis, Characterization, and Biological Studies of Organometallic Compounds of Re(I) with 2‐(5‐(4‐Nitrophenyl)‐3‐phenyl‐4,5‐dihydro‐1H‐pyrazol‐1‐yl)benzo[d]thiazole Based Derivatives
Organometallic Re(I) complexes and substituted 2‐(5‐(4‐nitrophenyl)‐3‐phenyl‐4,5‐dihydro‐1H‐pyrazol‐1‐yl)benzo[d] thiazole were effectively synthesized and characterized using a variety of spectroscopic techniques. Through viscosity measurements and absorption titration tests, their interaction with CT‐DNA was investigated. An intercalation binding mode was discovered, and molecular docking analysis confirmed this finding. Additionally, protein‐binding affinity was assessed by BSA binding assays. Tests of the synthesized compounds' antibacterial activity against three Gram‐negative and two Gram‐positive strains showed that Re(I) complexes exhibit more potent antibacterial activities than free ligands. SwissADME was used to predict pharmacokinetic parameters. DFT computations were used to calculate the compounds' molecular orbital energies. Furthermore, the anticancer potential was tested against MCF‐7 cells, and cytotoxicity was evaluated using a brine shrimp lethality assay. The compounds with ‐F and ‐OCH 3 groups, complexes C 4 and C 2 , have the lowest IC 50 values (92.48 µg/mL and 98.76 µg/mL, respectively). All complexes are more potent than carboplatin, with an IC 50 value of 165.28 µg/mL, and are closer to cisplatin (80.00 µg/mL). Pyrazole and thiazole moieties in broaden the range of biological activities. Especially in anticancer therapy, where their capacity to interact with many cellular targets might enhance efficacy and decrease resistance, these drugs have demonstrated encouraging outcomes.
- 30 May 2025
- Published by Wiley in ChemistrySelect
- Vol. 10 (21)
Synthesis, Characterization, and Biological Studies of Organometallic Compounds of Re(I) with 2‐(5‐(4‐Nitrophenyl)‐3‐phenyl‐4,5‐dihydro‐1H‐pyrazol‐1‐yl)benzo[d]thiazole Based Derivatives
Organometallic Re(I) complexes and substituted 2‐(5‐(4‐nitrophenyl)‐3‐phenyl‐4,5‐dihydro‐1H‐pyrazol‐1‐yl)benzo[d] thiazole were effectively synthesized and characterized using a variety of spectroscopic techniques. Through viscosity measurements and absorption titration tests, their interaction with CT‐DNA was investigated. An intercalation binding mode was discovered, and molecular docking analysis confirmed this finding. Additionally, protein‐binding affinity was assessed by BSA binding assays. Tests of the synthesized compounds' antibacterial activity against three Gram‐negative and two Gram‐positive strains showed that Re(I) complexes exhibit more potent antibacterial activities than free ligands. SwissADME was used to predict pharmacokinetic parameters. DFT computations were used to calculate the compounds' molecular orbital energies. Furthermore, the anticancer potential was tested against MCF‐7 cells, and cytotoxicity was evaluated using a brine shrimp lethality assay. The compounds with ‐F and ‐OCH 3 groups, complexes C 4 and C 2 , have the lowest IC 50 values (92.48 µg/mL and 98.76 µg/mL, respectively). All complexes are more potent than carboplatin, with an IC 50 value of 165.28 µg/mL, and are closer to cisplatin (80.00 µg/mL). Pyrazole and thiazole moieties in broaden the range of biological activities. Especially in anticancer therapy, where their capacity to interact with many cellular targets might enhance efficacy and decrease resistance, these drugs have demonstrated encouraging outcomes.
- Open Access
- 28 December 2024
- Published by Elsevier in Sustainable Chemistry for the Environment
- Vol. 9
Multi-component sustainable catalytic crafting of novel heterocyclic spiranes as topoisomerase II inhibitors
- 28 December 2024
- Published by Elsevier in Sustainable Chemistry for the Environment
- Vol. 9
Open AccessMulti-component sustainable catalytic crafting of novel heterocyclic spiranes as topoisomerase II inhibitors
- 16 December 2024
- Published by Elsevier in Computational Biology and Chemistry
- Vol. 115, 108313
Synthesis, characterization, and biological activities of novel organometallic compounds of rhenium(I) with 2-(2-benzylidenehydrazinyl) benzothiazole Schiff-base derivatives: Molecular docking, ADME, and DFT studies
- 16 December 2024
- Published by Elsevier in Computational Biology and Chemistry
- Vol. 115, 108313
Synthesis, characterization, and biological activities of novel organometallic compounds of rhenium(I) with 2-(2-benzylidenehydrazinyl) benzothiazole Schiff-base derivatives: Molecular docking, ADME, and DFT studies
- Open Access
- 29 November 2024
- Published by Qeios Ltd
Review of: "Investigation and Synthesis of Benzothiazole-Derived Schiff Base Ligand Against Mycobacterium tuberculosis"
The Schiff base ligand Benzhydrylidene-(6-methyl-benzothiazol-2-yl)-amine (MTA) was successfully synthesized by reacting 6-methyl-benzothiazol-2-ylamine with Diphenyl-methanone in ethanol. The product was thoroughly characterized using FT-IR, 1H-NMR,...
- 29 November 2024
- Published by Qeios Ltd
Open AccessReview of: "Investigation and Synthesis of Benzothiazole-Derived Schiff Base Ligand Against Mycobacterium tuberculosis"
The Schiff base ligand Benzhydrylidene-(6-methyl-benzothiazol-2-yl)-amine (MTA) was successfully synthesized by reacting 6-methyl-benzothiazol-2-ylamine with Diphenyl-methanone in ethanol. The product was thoroughly characterized using FT-IR, 1H-NMR,...
- 16 October 2024
- Published by Springer Nature in Journal of Fluorescence
- Vol. 35 (7) , 6079-6096
Influence of Pyridine Entangled Novel Hybrid Quinoxaline Spirane on the Fluorescence and Absorption Spectra of Biomolecules: Molecular Docking, Pharmacokinetic, and In-Vitro Biological Investigations
Spectroanalytical techniques are extensively employed in contemporary research to characterize compounds and assess their biological activity. The β-lactam ring containing twenty novel spiro quinoxaline-pyridine heterocyclic compounds (A - T) were synthesized and characterized using 1H NMR, 13C NMR, FT-IR, and mass spectrometry. The compounds must interact with DNA to adequately assess their potential anticancer action. Thus, their binding affinities with calf-thymus (CT) DNA and bovine serum albumin (BSA) were evaluated using a UV-visible spectrophotometer. The Kb value of compound-DNA and compound-BSA was found in the order of 0.51–2.53 M− 1 and 0.11–2.03 M− 1, respectively. Furthermore, a fluorescence quenching study was also carried out using a fluorescence spectrometer to explore DNA/BSA binding, and a partial intercalation type of binding was suggested. MTT assay was performed to evaluate the anticancer activity of the compounds. A docking study of all the compounds was performed with DNA (1 BNA), BSA (4F5S), and topoisomerase II (3QX3) using autodock vina software. SwissADME and admetSAR, two online platforms, were used to assess the pharmacokinetic profile and determine the drug-likeness of the synthesized compounds.
- 16 October 2024
- Published by Springer Nature in Journal of Fluorescence
- Vol. 35 (7) , 6079-6096
Influence of Pyridine Entangled Novel Hybrid Quinoxaline Spirane on the Fluorescence and Absorption Spectra of Biomolecules: Molecular Docking, Pharmacokinetic, and In-Vitro Biological Investigations
Spectroanalytical techniques are extensively employed in contemporary research to characterize compounds and assess their biological activity. The β-lactam ring containing twenty novel spiro quinoxaline-pyridine heterocyclic compounds (A - T) were synthesized and characterized using 1H NMR, 13C NMR, FT-IR, and mass spectrometry. The compounds must interact with DNA to adequately assess their potential anticancer action. Thus, their binding affinities with calf-thymus (CT) DNA and bovine serum albumin (BSA) were evaluated using a UV-visible spectrophotometer. The Kb value of compound-DNA and compound-BSA was found in the order of 0.51–2.53 M− 1 and 0.11–2.03 M− 1, respectively. Furthermore, a fluorescence quenching study was also carried out using a fluorescence spectrometer to explore DNA/BSA binding, and a partial intercalation type of binding was suggested. MTT assay was performed to evaluate the anticancer activity of the compounds. A docking study of all the compounds was performed with DNA (1 BNA), BSA (4F5S), and topoisomerase II (3QX3) using autodock vina software. SwissADME and admetSAR, two online platforms, were used to assess the pharmacokinetic profile and determine the drug-likeness of the synthesized compounds.